celecoxib has been researched along with Neutropenia in 3 studies
Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.
Excerpt | Relevance | Reference |
---|---|---|
"Neutropenia was the main side effect of the metronomic therapy." | 5.38 | Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. ( Kivivuori, SM; Nygaard, R, 2012) |
"Celecoxib with CCRT was well tolerated; the incidence of symptomatic radiation pneumonitis was 6." | 2.90 | Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical Trial. ( Bi, N; Chen, D; Deng, L; Feng, Q; Fu, Z; Hu, C; Hui, Z; Liang, J; Liu, L; Lv, J; Wang, J; Wang, L; Wang, W; Wang, X; Xiao, Z; Yang, X; Zhang, T; Zhou, Z, 2019) |
"Unresectable pancreatic cancer has few therapeutic options and a dismal prognosis." | 2.71 | Gemcitabine/Irinotecan/celecoxib in pancreatic cancer. ( Campbell, C; Harvey, H; Kerr, S; Legore, K; Lipton, A; Witters, L, 2004) |
"Neutropenia was the main side effect of the metronomic therapy." | 1.38 | Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. ( Kivivuori, SM; Nygaard, R, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bi, N | 1 |
Liang, J | 1 |
Zhou, Z | 1 |
Chen, D | 1 |
Fu, Z | 1 |
Yang, X | 1 |
Feng, Q | 1 |
Hui, Z | 1 |
Xiao, Z | 1 |
Lv, J | 1 |
Wang, X | 2 |
Zhang, T | 1 |
Deng, L | 1 |
Wang, W | 1 |
Wang, J | 1 |
Liu, L | 1 |
Hu, C | 1 |
Wang, L | 1 |
Nygaard, R | 1 |
Kivivuori, SM | 1 |
Lipton, A | 1 |
Harvey, H | 1 |
Witters, L | 1 |
Kerr, S | 1 |
Legore, K | 1 |
Campbell, C | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized Phase II Trial of Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer[NCT01503385] | Phase 2 | 100 participants (Anticipated) | Interventional | 2011-12-31 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for celecoxib and Neutropenia
Article | Year |
---|---|
Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Celecoxib; Chemoradi | 2019 |
Gemcitabine/Irinotecan/celecoxib in pancreatic cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2004 |
1 other study available for celecoxib and Neutropenia
Article | Year |
---|---|
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy.
Topics: Administration, Metronomic; Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherap | 2012 |